Fourth quarter 2025 worldwide procedures grew approximately 18% compared with the fourth quarter of 2024. Da Vinci procedures grew approximately 17% and Ion procedures grew approximately 44%. Average da Vinci system utilization increased 4% in the fourth quarter of 2025 as compared with the fourth quarter of 2024, primarily driven by adoption of da Vinci 5 in the U.S. and continued growth in utilization in OUS markets. Commenting on the announcement, Intuitive CEO Dave Rosa said, “We are pleased with our strong performance in the final quarter of 2025 and the full year. In 2025, we saw increased adoption and utilization of our surgical platforms, expanded product clearances and indications for use across geographies, and more than 3.1 million da Vinci procedures performed. As always, we remain focused on delivering the goals we share with our customers, centered on improving patient care and outcomes.”
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ISRG:
- 3 Best AI ETFs Investors Can’t Ignore in 2026
- Intuitive Surgical price target raised to $740 from $700 at Bernstein
- Intuitive Surgical price target raised to $714 from $621 at Goldman Sachs
- Intuitive Surgical price target raised to $616 from $589 at BTIG
- U.S. Chess Champion is Bullish on These Two New Stocks – ASTS and SNDK